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Relatives of patients with aneurysmal subarachnoid haemorrhage (SAH) have an increased risk of this type of
stroke. In a population-based study, we analysed individualized risks of SAHaccording to the number of affected
first-degree relatives. We retrieved all patients diagnosed with SAH in 2001^05 from the Swedish Inpatient
Register. For each of the 5282 patients, we identified five controls (n=26 402) through the nationwide Register
of Total Population. Through the Multi-generation Register, we retrieved all first-degree relatives for patients
and controls and checkedwhether these130 373 relatives had been diagnosedwith SAH.Bymeans of conditional
logistic regression, we calculated odds ratios with corresponding 95% confidence intervals (95% CI) for the risk of
SAHaccording to the number of affected relatives, and to the gender, age and type of kinship of the patient and
affected relative.The odds ratio of SAH for individuals with one affected first-degree relative was 2.15 (95% CI
1.77^2.59). For individuals with two affected first-degree relatives, the odds ratio was 51.0 (95% CI 8.56^1117).
Gender, age and type of kinship did not influence the risk for individuals with one or more affected relatives.
The risk of SAH is slightly increased in the cases with one, but strongly increased in cases with two or more
affected first-degree relatives.The latter strongly increased risk corresponds to a considerable absolute life-time
risk of SAH and underscores the need to consider screening for aneurysms in these individuals.
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Introduction
Subarachnoid haemorrhage (SAH) from a ruptured aneu-
rysm is a rare but devastating subset of stroke (Hop et al.,
1997; Hackett et al., 2000; Inagawa, 2001; Stegmayr et al.,
2004; Koffijberg et al., 2008) that occurs at a relatively
young age. Individuals have an increased risk of SAH if
a first-degree relative has had one (Ronkainen et al., 1993;
Bromberg et al., 1995; Schievink et al., 1995; Gaist et al.,
2000; Teasdale et al., 2005; Sundquist et al., 2007). The
prevalence of unruptured aneurysms in individuals with one
first-degree relative with SAH is slightly increased compared
with those without first-degree relatives with SAH
(Raaymakers and MARS study group, 1999). The prevalence
of unruptured aneurysms is even higher in individuals with
two or more affected relatives (Ronkainen et al., 1997;
Wermer et al., 2003). However, the actual risk of SAH in
individuals with two or more relatives with SAH is unknown
since families with two or more affected first-degree relatives
are very rare. Moreover, individuals from these families may
nowadays ask for screening and preventive treatment of
asymptomatic aneurysms, which may affect the natural
history. A study on the familial risk of SAH in Scotland
found a trend towards an increasing risk of SAH as more
and more closely related relatives experienced an SAH
(Teasdale et al., 2005). However, the increased risk was
not statistically significant, probably because of the small
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number of patients with two or more affected first-degree
relatives with SAH. Recently, the risk of SAH in siblings was
studied in the Swedish population (Sundquist et al., 2007).
A risk ratio of 2.75 was found for siblings of SAH patients.
However, this study was too small to assess the risk of
multiple affected relatives. We performed a population based
case–control study in the Swedish population to assess the
risk of SAH according to the number of affected relatives
and type of kinship.
Material and Methods
Cases and controls
The patients in this patient–control study were identified from
the Swedish Inpatient Register 1964–2006 (Anonymous, 1998)
that contains individual-based information on discharges from
inpatient care coded according to International Classification of
Diseases (ICD) [versions 7–10], with a population-based (county-
wise) coverage that encompassed 80% of Sweden in the mid-1970s
and 100% since 1987. We included patients admitted to a hospital
between 2001 and 2005 with SAH as the primary diagnosis, who
were 15 years or older and who had no prior admission with SAH as
either primary or secondary diagnosis in the Inpatient Register.
Through the nationwide Register of Total Population, which since
1969 comprises the Swedish Census Register, we matched five
controls to each case based on sex, year of birth, marital status
and county of residence in the year of the index patient’s admission
with SAH. This selection yielded 5282 cases and 26 402 controls.
For eight cases we were not able to provide all five controls.
Family members
The Swedish Multi-generation Register (Anonymous, 2006)
includes information on parent–offspring relations for Swedish
citizens born in 1932 or later. For both cases and controls, we
retrieved all first-degree relatives (parents, children and siblings).
For patients and controls born before 1932, the family history
could only be provided by children and siblings. This selection
yielded 21 724 relatives for cases and 108 649 relatives for controls,
in total 130 373 first-degree relatives.
Assessing family history
For all the 130 373 identified relatives, all records were retrieved
from both the Swedish Inpatient Register and the Cause of Death
Register. The latter register includes details on causes of death
in patients who died without being admitted to the hospital.
A relative was defined as being affected by SAH when either an
admission to a hospital with a primary or secondary diagnosis
of SAH was recorded or when the underlying or contributing
cause of death of the relative was SAH. We only considered
events that occurred before the date of the SAH of a case or the
corresponding time for the controls.
Data analysis
Using conditional logistic regression, we calculated odds ratios
with corresponding 95% confidence intervals (CIs) for the risk of
SAH according to the family history. Due to small observed
numbers, exact mid-P corrected 95% CIs were calculated when
assessing the risk associated with having more than one affected
relative. We aggregated counties into three regions for analysis:
northern, central and southern Sweden. The risk associated with
family history in relation to the individuals’ sex, age at diagnosis
and region was assessed by means of stratification.
Results
Tables 1 and 2 show the baseline characteristics of the 5282
patients and the 26 402 controls. The odds ratios of SAH
for individuals with one or more affected first-degree
relatives was 2.28 (95% CI 1.89–2.74). Compared with
Table 1 Risk ratio of SAH according to number and type of affected relatives
SAH patients n=5282 Controls n=26 402 Odds ratio 95% CI
Number of relatives with SAH
No affected relative 5116 (96.86%) 26 030 (98.59%) 1 Reference
1 relative 156 (2.95%) 371 (1.41%) 2.15 1.77^2.59
52 relatives 10 (0.19%) 1 (0.00%) 51.0 8.56^1117
Affected relative
No affected relative 5116 (96.86%) 26 030 (98.59%) 1 Reference
Child 92 (1.74%) 181 (0.69%) 2.02 1.31^3.10
Sibling 46 (0.87%) 104 (0.39%) 2.40 1.72^3.34
Parent 27 (0.51%) 64 (0.24%) 2.35 1.82^3.03
Exact confidence interval using the mid-P correction for discreteness of the distribution.
Table 2 The odds ratio for having family history, defined
as one or more affected first degree relatives, compared










Male 2169 (41%) 10 834 (41%) 1.84 1.33^2.53
Female 3113 (59%) 15568 (59%) 2.56 2.04^3.22
Age (years)
15^49 1251 (24%) 6250 (24%) 1.92 1.33^2.76
50^59 1318 (25%) 6592 (25%) 2.27 1.64^3.15
60^69 1131 (21%) 5654 (21%) 2.64 1.86^3.74
570 1582 (30%) 7906 (30%) 2.40 1.44^3.99
Geographical region
Northern 603 (11%) 3013 (11%) 2.64 1.55^4.49
Central 2132 (40%) 10 659 (40%) 2.33 1.75^3.10
Southern 2547 (48%) 12730 (48%) 2.14 1.64^2.83
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individuals without family history, the risk ratio was 2.15
(95% CI 1.77–2.59) for individuals with only one affected
relative and 51.0 (95% CI 8.56–1117) for individuals with
two or more affected relatives (Table 1). The risk associated
with family history was approximately the same irrespective
of type of kinship between the person at risk and the
affected relative (Table 1). The effect of family history was
not significantly modified by sex and age of the person at
risk or by geographical region (Table 2).
Discussion
In this large population-based study, we found that having a
relative with SAH increases the risk of SAH and that this risk
is highly dependent on the number of affected relatives.
Although the odds ratios exceeded two, with one affected
relative, the absolute risk of SAH remains limited. With two
or more affected relatives, a steep rise in risk was observed.
This increased risk of SAH is independent of the age and
gender of the person at risk, the relation with the affected
relative and the gender of the affected relative. The high-risk
ratio for SAH in individuals with two affected relatives
implies a considerable absolute risk of SAH for such
individuals. If we assume a 0.7% life-time risk of SAH in
the general population (de Rooij et al., 2007; Koffijberg et al.,
2008), the data in this study would suggest an absolute
life-time risk of SAH of 26% for individuals with two or more
affected relatives, with a lower confidence limit of 6%.
The increased risk of SAH in first-degree relatives of SAH
patients we found in this population-based study is in line
with the findings of other studies (Ronkainen et al., 1993;
Bromberg et al., 1995; Schievink et al., 1995; Gaist et al., 2000;
Okamoto et al., 2003; Teasdale et al., 2005). In previous
studies, the risk of SAH in first-degree relatives was in general
somewhat higher than in our study but CIs in these previous
studies were wide and included the risk ratios found in the
present study (Ronkainen et al., 1993; Bromberg et al., 1995;
Schievink et al., 1995; Gaist et al., 2000; Okamoto et al., 2003;
Teasdale et al., 2005). A recent study in Sweden on the risk of
subarachnoid haemorrhage in siblings found a similar risk for
one affected relative (Sundquist et al., 2007). Our current
study includes data on more individuals and is taking into
account a longer period of observation. Therefore, we were
able to analyse the effect of multiple affected relatives on the
risk of SAH. Although we used the same databases as the
previous study, overlap between these studies was limited to
affected sibpairs, with one sibling affected during the year
2001. We are not aware of any studies regarding the risk of
SAH in families with two or more affected relatives. As the
cause of SAH is most likely multifactorial in familial as well as
sporadic SAH, the risk and familial risk ratio of SAH may vary
between different populations (de Rooij et al., 2007). In
contrast to previous studies (Schievink et al., 1995;
Raaymakers and MARS study group, 1999), we found the
risk of SAH to be equally increased for siblings, parents and
children of SAH patients.
The strength of the current study lies in the large number
of patients with SAH and controls that were included. As
families with two or more affected relatives are very rare,
very large databases with diagnoses of hospital admissions
and causes of death are needed to provide enough data
to assess the risk of SAH in a population-based study.
The database with information of all first-degree relatives
of Swedish residents born after 1932 allowed us to assess
the prevalence of SAH in relatives of affected patients.
We included cases and controls from 2001 to 2005 but
recorded SAH in their relatives in a much larger time span
(1964–2005). Although this study provides information
on the prevalence of SAH in first-degree relatives of
SAH patients, it does not give any information about the
incidence or prevalence of SAH in Sweden, as we identified
index patients through the Swedish Inpatient Register only
and not through the Cause of Death Register. Because most
data in our study originate from a time before screening
and preventive treatment was introduced, it is highly
unlikely that the introduction of screening for intracranial
aneurysms in familial SAH affected our results. Notably,
had screening and preventive treatment of detected aneu-
rysms played a role, this would have led to an underesti-
mation of the risk in families with two or more affected
relatives. To further exclude the influence of screening,
we have included only patients with a diagnosis of SAH
and not patients with a diagnosis of aneurysm because an
unruptured aneurysm may have been detected through
screening. The current study is probably a last chance
to study the risk of SAH in relatives of families with two
or more SAH patients because nowadays screening and
preventive treatment is usually performed in such families.
This will obviously alter the natural history in such families.
A potential weakness of our study is the diagnosis of
SAH, which was based on ICD coding. Since the index
patients with SAH were selected in 2001 through 2005, the
coding will have been stable over time and the diagnosis
will have been accurate as CT scans were widely available
in Sweden during these years. However, for the relatives
who had an SAH in earlier years, diagnosis and ICD
coding could have been less reliable because CT scans were
not available before the 1980s and were not available at all
times during the 1980s of the 20th century. There is
however no reason to believe that the inaccuracy of the
diagnosis would be different between relatives of cases and
relatives of controls, more so since familial aggregation of
SAH has been recognized only since the mid-1990s of the
20th century (Bromberg et al., 1995; Schievink et al., 1995;
Ronkainen et al., 1997). Another issue is that we probably
have not excluded all instances of perimesencephalic non-
aneurysmal subarachnoid haemorrhage, not only because
with older ICD coding systems it was more difficult to
separate this diagnosis but also because the diagnosis was
not recognized before 1985 (van Gijn et al., 1985). However,
we do not feel this will have influenced our results: first,
because perimesencephalic SAH constitutes only 5% of
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all SAHs (Flaherty et al., 2005) and second, because familial
perimesencephalic haemorrhage is very rare if it exists at all.
In the literature, only one family with two relatives with
perimesencephalic haemorrhage has been reported (Tieleman
et al., 2006), which may very well be a chance finding.
Another potential weakness inherent to population-
based studies is that not all databases are 100% complete.
If diagnoses are missing, it is possible that we have under-
estimated the risk of SAH due to affected first-degree
relatives. On the contrary, the risk might be overestimated
if the diagnosis of SAH is better-recognized in case of a
positive family history. However, as SAH causes very severe
and sudden symptoms, it seems unlikely that a diagnosis
would go unnoticed in patients with or without family
history. We therefore feel that although we cannot entirely
exclude the possibility that the risk we found is over-
estimated by this effect, it is not very likely.
We found 2% fewer parents for the cases than for the
controls. This could be caused by early death of the parents
of the cases, such as one would expect in familial SAH. Also,
it is possible that we missed index cases as we identified
our index cases through the Swedish Inpatient Register
and we did not use the Cause of Death Register for index
patient identification (Huang and Van Gelder, 2002). Since
familial SAH may have a worse prognosis than incidental
SAH (Bromberg et al., 1995), we might have missed relatively
more patients with familial SAH than with sporadic SAH.
Therefore, our estimates of the increased risk of SAH due
to affected first-degree relatives might be conservative.
Although people with one relative with SAH have an
increased risk of SAH, the absolute risk of SAH is still
low. This low absolute risk underscores current recom-
mendations that, in general, screening for aneurysms is
not recommended in cases of one affected relative (MARS
study group, 1999). The high risk ratio that we found for
individuals with two or more affected first-degree relatives
has a wide CI and provides no exact certainty about the
life-time risk of SAH of these individuals. Yet, the risk
ratio clearly shows that the absolute life-time risk of SAH in
case of two or more affected relatives is considerable and
screening for aneurysms should definitely be considered in
such individuals. Because aneurysms develop during life
and can also develop after initial screening, screening
for aneurysms should be repeated (Wermer et al., 2003).
The optimal screening interval should be assessed in future
studies, taking into account the irregular pattern of
aneurysm development over time (Koffijberg et al., 2007).
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